Genetic Engineering and Biotechnology News reports results of a new Alzheimer's study. To read the article, click here.
At last month’s annual conference of the European, Middle Eastern and African Society for Biopreservation and Biobanking (ESBB) in Leipzig, Germany, CryoXtract presented a poster on using frozen aliquotting for the preservation of analytical profiles in neurodegenerative research. The poster, entitled “Preserving Analytical Profiles of CNS Samples for Neurodegenerative Disease Research using Frozen Aliquotting Sample Handling Technology,” detailed potential improvements in sample processing techniques for central nervous system (CNS) disease tissue and biofluids biospecimens.
Freeze-thaw damage to highly sensitive CNS biospecimens can dramatically hinder the growing amount of research in the fields of neurodegenerative disease. By integrating frozen aliquotting into modern neurobiological research, greater access to high quality annotated CNS samples could yield improved diagnostic and treatment options for the growing populations facing diseases such as Alzheimer's and Parkinson's.